NCT01931644

Brief Summary

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17,667

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 29, 2013

Completed
10.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

April 18, 2024

Status Verified

April 1, 2024

Enrollment Period

10.8 years

First QC Date

August 23, 2013

Last Update Submit

April 16, 2024

Conditions

Keywords

ADD/ADHDAlopecia AreataAnkylosing SpondylitisAsthmaAtopic Dermatitis EczemaBeta ThalassemiaBipolar DisorderBreast CancerCeliac DiseaseCervical CancerChronic Inflammatory Demyelinating PolyneuropathyChronic Kidney DiseasesChronic Obstructive Pulmonary DiseaseColon CancerColorectal CancerCrohn's DiseaseCystic FibrosisDepressionDiabete MellitusDuchenne Muscular DystrophyEndometriosisEpilepsyFacioscapulohumeral Muscular DystrophyG6PD DeficiencyGeneral Anxiety DisorderHepatitis BHereditary Hemorrhagic TelangiectasiaHIV/AIDSHuman Papilloma VirusHuntington's DiseaseIdiopathic Thrombocytopenic PurpuraInsomniaKidney CancerLeukemiaLung CancerLupus NephritisLymphomaMelanomaMultiple MyelomaMultiple SclerosisMyositisMyotonic DystrophyOvarian CancerPancreatic CancerParkinson's DiseasePolycystic Kidney DiseasesProstate CancerPsoriasisPsoriatic ArthritisRosaceaSclerodermaSickle Cell AnemiaSickle Cell DiseaseSickle Cell TraitSjogren's SyndromeSkin CancerSpinal Muscular AtrophySystemic Lupus ErythematosusThrombotic Thrombocytopenic PurpuraTrisomy 21Ulcerative Colitis

Outcome Measures

Primary Outcomes (1)

  • Biospecimen & Clinical Data Collection

    To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results

    10 years

Study Arms (2)

Health Condition

Collect blood and other optional biospecimens from participants with a diagnosed health condition

Healthy Control

Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Diagnosed with a health condition

You may qualify if:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live in USA

You may not qualify if:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sanguine Biosciences

Los Angeles, California, 91403, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine

MeSH Terms

Conditions

Alopecia AreataSpondylitis, AnkylosingAsthmabeta-ThalassemiaBipolar DisorderBreast NeoplasmsCeliac DiseaseUterine Cervical NeoplasmsPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingRenal Insufficiency, ChronicPulmonary Disease, Chronic ObstructiveColonic NeoplasmsColorectal NeoplasmsCrohn DiseaseCystic FibrosisDepressionDiabetes MellitusMuscular Dystrophy, DuchenneEndometriosisEpilepsyMuscular Dystrophy, FacioscapulohumeralGlucosephosphate Dehydrogenase DeficiencyGeneralized Anxiety DisorderHepatitis BTelangiectasia, Hereditary HemorrhagicAcquired Immunodeficiency SyndromeHuntington DiseasePurpura, Thrombocytopenic, IdiopathicSleep Initiation and Maintenance DisordersKidney NeoplasmsLeukemiaLung NeoplasmsLupus NephritisLymphomaMelanomaMultiple MyelomaMultiple SclerosisMyositisMyotonic DystrophyOvarian NeoplasmsPancreatic NeoplasmsParkinson DiseasePolycystic Kidney DiseasesProstatic NeoplasmsPsoriasisArthritis, PsoriaticRosaceaScleroderma, DiffuseAnemia, Sickle CellSickle Cell TraitSjogren's SyndromeSkin NeoplasmsMuscular Atrophy, SpinalLupus Erythematosus, SystemicPurpura, Thrombotic ThrombocytopenicDown SyndromeColitis, Ulcerative

Condition Hierarchy (Ancestors)

AlopeciaHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesAxial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesThalassemiaAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBipolar and Related DisordersMood DisordersMental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesMalabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPolyradiculoneuropathyAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesAutoimmune DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesMale Urogenital DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsColonic DiseasesRectal DiseasesInflammatory Bowel DiseasesGastroenteritisPancreatic DiseasesInfant, Newborn, DiseasesBehavioral SymptomsBehaviorGlucose Metabolism DisordersEndocrine System DiseasesMuscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesGenetic Diseases, X-LinkedBrain DiseasesCentral Nervous System DiseasesCarbohydrate Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsAnxiety DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitisLiver DiseasesHemostatic DisordersVascular DiseasesCardiovascular DiseasesTelangiectasisHemorrhagic DisordersVascular MalformationsCardiovascular AbnormalitiesCongenital AbnormalitiesHIV InfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsSlow Virus DiseasesImmunologic Deficiency SyndromesBasal Ganglia DiseasesDementiaChoreaDyskinesiasMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesCognition DisordersNeurocognitive DisordersPurpura, ThrombocytopenicPurpuraBlood Coagulation DisordersThrombotic MicroangiopathiesThrombocytopeniaBlood Platelet DisordersCytopeniaHemorrhageSkin ManifestationsSigns and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersUrologic NeoplasmsNeoplasms by Histologic TypeRespiratory Tract NeoplasmsThoracic NeoplasmsGlomerulonephritisNephritisConnective Tissue DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms, Nerve TissueNevi and MelanomasNeoplasms, Plasma CellParaproteinemiasBlood Protein DisordersDemyelinating Autoimmune Diseases, CNSMyotonic DisordersEndocrine Gland NeoplasmsOvarian DiseasesAdnexal DiseasesGonadal DisordersParkinsonian DisordersSynucleinopathiesKidney Diseases, CysticAbnormalities, MultipleCiliopathiesGenital Neoplasms, MaleGenital Diseases, MaleProstatic DiseasesSkin Diseases, PapulosquamousScleroderma, SystemicArthritis, RheumatoidRheumatic DiseasesXerostomiaSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesSpinal Cord DiseasesMotor Neuron DiseaseThrombophiliaIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsChromosome DisordersColitis

Study Officials

  • Houman Hemmati, MD

    Sanguine Biosciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2013

First Posted

August 29, 2013

Study Start

July 1, 2013

Primary Completion

April 1, 2024

Study Completion

April 1, 2024

Last Updated

April 18, 2024

Record last verified: 2024-04

Locations